Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasALLAML
New Drug Approvals Are the Wrong Metric for Cancer PolicyMarch 20, 2024Mixed TopicsDLBCLPediatricsPatient & Survivor CareAggressive LymphomasALLAML
Does Exercise Reduce Cancer Risk? It’s Just Not That SimpleMarch 8, 2024Mixed TopicsPatient & Survivor CarePediatrics
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineDLBCLAggressive LymphomasALLAML
New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?February 28, 2024PediatricsPatient & Survivor CareB Cell LymphomaCLLMixed TopicsALL
Democratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLBleeding Disorders
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Gene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
ASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
Study confirms small blood cancer risk from CT scansNovember 15, 2023ALLCLLAMLMyelodysplastic SyndromeCMLPediatrics
DEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicineDLBCLALLAggressive LymphomasAMLB Cell LymphomaCLL
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CareDLBCLAggressive LymphomasALLAMLAnemiaB Cell Lymphoma
